PureTech Health PLC
LSE:PRTC

Watchlist Manager
PureTech Health PLC Logo
PureTech Health PLC
LSE:PRTC
Watchlist
Price: 168.6 GBX -2.09% Market Closed
Market Cap: 403.6m GBX
Have any thoughts about
PureTech Health PLC?
Write Note

PureTech Health PLC
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PureTech Health PLC
Total Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
PureTech Health PLC
LSE:PRTC
Total Equity
$464.1m
CAGR 3-Years
-12%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Equity
$6B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
3%
Gilead Sciences Inc
NASDAQ:GILD
Total Equity
$18.4B
CAGR 3-Years
-5%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Total Equity
$7.5B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Equity
$15.6B
CAGR 3-Years
18%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Equity
$29.3B
CAGR 3-Years
19%
CAGR 5-Years
23%
CAGR 10-Years
28%

See Also

What is PureTech Health PLC's Total Equity?
Total Equity
464.1m USD

Based on the financial report for Dec 31, 2023, PureTech Health PLC's Total Equity amounts to 464.1m USD.

What is PureTech Health PLC's Total Equity growth rate?
Total Equity CAGR 5Y
11%

Over the last year, the Total Equity growth was -14%. The average annual Total Equity growth rates for PureTech Health PLC have been -12% over the past three years , 11% over the past five years .

Back to Top